Trial Profile
A Phase I/II Study Of COX-2 Inhibitor, CELEBREX (CELECOXIB), And Chemoradiation In Patients With Locally Advanced Cervical Cancer.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 21 Nov 2013
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary) ; Cisplatin; Fluorouracil
- Indications Cervical cancer
- Focus Therapeutic Use
- 27 Sep 2005 New trial record.